Literature DB >> 9158219

Acute massive gentamicin intoxication in a patient with end-stage renal disease.

C M Lu1, S H James, Y H Lien.   

Abstract

A 65-year-old man with end-stage renal disease on continuous ambulatory peritoneal dialysis accidentally received an acute massive overdose of gentamicin as a treatment of peritonitis. The patient developed acute vestibular dysfunction and hearing loss following the overdose. His serum gentamicin had reached the extremely toxic level of 220 microg/mL. To remove the gentamicin, the patient received hemodialysis and hemoperfusion immediately. This was followed by two more courses of hemodialysis during the following 2 days. The gentamicin level was brought down to 10 microg/mL after the third hemodialysis. Moderate and persistent high-frequency hearing loss was documented with serial audiograms. The patient made a gradual but incomplete recovery from the vestibular dysfunction. The complications of gentamicin toxicity and its management are discussed with respect to our patient.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9158219     DOI: 10.1016/s0272-6386(96)90263-2

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  3 in total

1.  Reagentless measurement of aminoglycoside antibiotics in blood serum via an electrochemical, ribonucleic acid aptamer-based biosensor.

Authors:  Aaron A Rowe; Erin A Miller; Kevin W Plaxco
Journal:  Anal Chem       Date:  2010-09-01       Impact factor: 6.986

2.  Massive gentamicin overdose in a 14-month-old.

Authors:  Scott J Schurman; Vickie Keeler; Thomas R Welch
Journal:  Pediatr Nephrol       Date:  2008-08-12       Impact factor: 3.714

3.  A wrinkled structure of gold film greatly improves the signaling of electrochemical aptamer-based biosensors.

Authors:  Shaoguang Li; Lancy Lin; Xueman Chang; Zhixiao Si; Kevin W Plaxco; Michelle Khine; Hui Li; Fan Xia
Journal:  RSC Adv       Date:  2021-01-06       Impact factor: 3.361

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.